Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus
NCT06915233Phase 3Recruiting
- Sponsor
- Vericel
- Start
- May 2026
- Primary completion
- Jul 2030
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous cultured chondrocytes on porcine collagen membrane in Chondral defect, Articular cartilage defect, sponsored by Vericel. Started May 2026; status: recruiting.
02
Drugs
autologous cultured chondrocytes on porcine collagen membrane
03
Conditions
Chondral defectArticular cartilage defect
Beyond the preview
Go deeper on NCT06915233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915233.